Targeting the CD163/SRCR5 axis for PRRSV control: Current evidence and future perspectives
The Thai Journal of Veterinary Medicine · 19.11.2026 · 56 (4) · 1-19
DOI: 10.56808/2985-1130.4120 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thai Journal of Veterinary Medicine, online erschienen am 19.11.2026. Verfasst von Han-Yu Wu und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Porcine reproductive and respiratory syndrome (PRRS), caused by PRRS virus (PRRSV), is an economically destructive disease for global swine production. Conventional vaccination alone often provides incomplete and variable protection against genetically diverse PRRSV strains and therefore is unlikely to achieve durable control when used without complementary herd-level measures. Driven by PRRSV’s high genetic variability, fast mutation rate, and potent immune-evasion mechanisms, these vaccines fall into a repeated “antigenic chase” and provide limited cross-protection against heterologous field strains. Research is now shifting toward host-directed strategies targeting conserved host dependency factors. The CD163/scavenger receptor cysteine-rich domain 5 (SRCR5) axis, a genotype-conserved receptor required for PRRSV entry into porcine alveolar macrophages, represents a central target. This review outlines the structure-function features of CD163/SRCR5 and its molecular roles during viral entry and fusion. Two intervention approaches are summarized: CRISPR-Cas9 genome editing, mainly selective modification or deletion of SRCR5 to produce heritable resistance in experimental challenge settings while preserving most CD163 physiological functions; and transient receptor-blocking tools such as monoclonal antibodies, nanobodies, and small-molecule inhibitors that interrupt virus-receptor binding. We assess their translational prospects, covering cross-genotype performance, resistance persistence, viral escape hazards, and physiological side effects. A multi-tiered control framework integrating host genetic resistance, routine vaccination, biosecurity and farm management is proposed. We also highlight outstanding scientific obstacles and future research priorities. Host-directed interventions against CD163/SRCR5 represent a promising complementary approach to address the limitations of antigen-focused strategies, but important questions regarding breadth, long-term safety, and integration with existing control programs remain to be resolved.
Zitieren
APA
Wu, H., Xu, Q., Gao, M., Li, L., Li, L., & Wu, Y. (2026). Targeting the CD163/SRCR5 axis for PRRSV control: Current evidence and future perspectives. The Thai Journal of Veterinary Medicine, 56(4), 1-19. https://doi.org/10.56808/2985-1130.4120
Vancouver
Wu H, Xu Q, Gao M, Li L, Li L, Wu Y. Targeting the CD163/SRCR5 axis for PRRSV control: Current evidence and future perspectives. The Thai Journal of Veterinary Medicine. 2026;56(4):1-19. doi:10.56808/2985-1130.4120
BibTeX
@article{Wu2026,
author = {Wu, Han-Yu and Xu, Qiu-Ting and Gao, Min and Li, Lan-Lan and Li, Lin and Wu, Yun-Kun},
title = {Targeting the CD163/SRCR5 axis for PRRSV control: Current evidence and future perspectives},
journal = {The Thai Journal of Veterinary Medicine},
year = {2026},
volume = {56},
number = {4},
pages = {1--19},
doi = {10.56808/2985-1130.4120}
}
EUVIMED